Improvement in circulating endothelial progenitor cells pool after cardiac resynchronization therapy: increasing the list of benefits.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
24 05 2020
Historique:
received: 03 03 2020
accepted: 06 05 2020
revised: 16 04 2020
entrez: 26 5 2020
pubmed: 26 5 2020
medline: 22 6 2021
Statut: epublish

Résumé

Recent studies suggest that circulating endothelial progenitor cells (EPCs) may influence the response to cardiac resynchronization therapy (CRT). The aim of this study was to evaluate the effect of CRT on EPC levels and to assess the impact of EPCs on long-term clinical outcomes. Prospective study of 50 patients submitted to CRT. Two populations of circulating EPCs were quantified previously to CRT implantation: CD34 The proportion of non-responders to CRT was 42% and tended to be higher in patients with an ischemic vs non-ischemic etiology (64% vs 35%, p = 0.098). Patients with ischemic cardiomyopathy (ICM) showed significantly lower CD34 Patients with ICM showed significantly lower levels of circulating EPCs when compared to their counterparts. CRT seems to improve the pool of endogenously circulating EPCs and reduced baseline EPC levels seem not to influence long-term outcomes after CRT.

Sections du résumé

BACKGROUND
Recent studies suggest that circulating endothelial progenitor cells (EPCs) may influence the response to cardiac resynchronization therapy (CRT). The aim of this study was to evaluate the effect of CRT on EPC levels and to assess the impact of EPCs on long-term clinical outcomes.
POPULATION AND METHODS
Prospective study of 50 patients submitted to CRT. Two populations of circulating EPCs were quantified previously to CRT implantation: CD34
RESULTS
The proportion of non-responders to CRT was 42% and tended to be higher in patients with an ischemic vs non-ischemic etiology (64% vs 35%, p = 0.098). Patients with ischemic cardiomyopathy (ICM) showed significantly lower CD34
CONCLUSIONS
Patients with ICM showed significantly lower levels of circulating EPCs when compared to their counterparts. CRT seems to improve the pool of endogenously circulating EPCs and reduced baseline EPC levels seem not to influence long-term outcomes after CRT.

Identifiants

pubmed: 32448383
doi: 10.1186/s13287-020-01713-8
pii: 10.1186/s13287-020-01713-8
pmc: PMC7245793
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Références

Int J Cardiol. 2007 Jul 31;119(3):344-8
pubmed: 17070610
Thromb Haemost. 2016 Aug 1;116(2):309-16
pubmed: 27412580
Pacing Clin Electrophysiol. 2014 Jun;37(6):731-9
pubmed: 24383551
N Engl J Med. 2005 Sep 8;353(10):999-1007
pubmed: 16148285
Eur Heart J. 2004 Sep;25(18):1614-9
pubmed: 15351160
Circulation. 2005 Jun 7;111(22):2981-7
pubmed: 15927972
Am Heart J. 2009 Mar;157(3):457-66
pubmed: 19249415
PLoS One. 2014 Apr 14;9(4):e94614
pubmed: 24732141
Europace. 2013 Jun;15(6):835-44
pubmed: 23487543
Am J Cardiol. 2005 Jun 15;95(12):1436-40
pubmed: 15950566
Can J Cardiol. 2013 Dec;29(12):1657-64
pubmed: 24054922
Stroke. 2008 May;39(5):1441-7
pubmed: 18356550
Heart. 2007 Sep;93(9):1046-50
pubmed: 17277352
Circulation. 2004 Apr 6;109(13):1615-22
pubmed: 15037527
Eur Heart J. 2007 May;28(10):1258-64
pubmed: 17395679
J Cell Mol Med. 2004 Oct-Dec;8(4):498-508
pubmed: 15601578
Circulation. 2004 Sep 7;110(10):1209-12
pubmed: 15249502
Circ Res. 2001 Jul 6;89(1):E1-7
pubmed: 11440984
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J. 2013 Dec;34(46):3547-56
pubmed: 23900696
Pacing Clin Electrophysiol. 2006 Mar;29(3):255-61
pubmed: 16606392
N Engl J Med. 2002 Jun 13;346(24):1845-53
pubmed: 12063368
Circulation. 1991 Oct;84(4):1589-96
pubmed: 1914099
Circ Heart Fail. 2017 Aug;10(8):
pubmed: 28790053
Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1185-9
pubmed: 12714439
Clin Biochem. 2013 Feb;46(3):230-4
pubmed: 23159290
Eur Heart J. 2005 Jan;26(1):65-9
pubmed: 15615801

Auteurs

Gonçalo Cristóvão (G)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.
Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

James Milner (J)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.

Pedro Sousa (P)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.

Miguel Ventura (M)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.

João Cristóvão (J)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.

Luís Elvas (L)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.

Artur Paiva (A)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.
Cytometry Operational Management Unit, Clinical Pathology Service, Coimbra Hospital and University Centre, Coimbra, Portugal.
Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department Biomedical Laboratory Sciences, Coimbra, Portugal.

Lino Gonçalves (L)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal.
Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Clinical Academic Center of Coimbra, Coimbra, Portugal.
Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal.

Carlos Fontes Ribeiro (CF)

Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal.

Natália António (N)

Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal. natalia.antonio@gmail.com.
Faculty of Medicine, University of Coimbra, Coimbra, Portugal. natalia.antonio@gmail.com.
Clinical Academic Center of Coimbra, Coimbra, Portugal. natalia.antonio@gmail.com.
Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. natalia.antonio@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH